Dr. George Church Joins Pattern Computer Advisory Board

REDMOND, W.A., Mar. 16, 2021 – Pattern Computer® Inc. is pleased to announce that Dr. George Church, a well-known pioneer in the fields of genetics, molecular engineering, and chemistry, is joining the Pattern Computer, Inc. (PCI) Advisory Board.

In 1984, Dr. Church developed the first direct genomic sequencing method, which resulted in the first genome sequence. He helped initiate the Human Genome Project in 1984 and the Personal Genome Project in 2005.

Dr. Church is the Founding Core Faculty & Lead, Synthetic Biology at the Wyss Institute at Harvard University; Professor of Genetics at Harvard Medical School; and Professor of Health Sciences and Technology at Harvard and the Massachusetts Institute of Technology (MIT). He was Director of the U.S. Department of Energy Technology Center from 1987 to 2021 and Director of the National Institutes of Health, Center of Excellence in Genomic Science from 2004 to 2021.

Dr. Church has received numerous awards including the 2011 Bower Award and the Prize for Achievement in Science from the Franklin Institute; as well as election to the National Academy of Sciences and Engineering.

“We are absolutely delighted to have the opportunity to work with George, and to benefit from his well-known abilities and successes; his decision to join Pattern Computer’s Advisory Board continues to support our efforts to align with the most remarkable thinkers and discoverers in the cross section of computing and medicine. With George’s addition, we are well on our way to having the most capable and exciting team in bio, and in the larger realm of Pattern Discovery,” said Mark R. Anderson, CEO of Pattern Computer.

Pattern maintains it focus on innovation while driving for future growth; progress continues in the evaluation of two therapy treatments for breast cancer. After successfully completing two tiers of in vitro organoid testing at Lawrence Berkeley National Laboratory, demonstrating “significant synergistic interaction” in killing malignant tumor cells with statistically “low-to-no adverse effects” on healthy cells.

“Over the past decades, the fields of genomic science and computational biomedicine have converged in powerful ways toward unraveling biologic mysteries and improving human health,” Church said. “Yet the challenges that remain ahead of us are as great as the opportunities, and I look forward to helping solve these challenges and to collaborating with the PCI team in their efforts to do so.”

About Pattern Computer

Pattern Computer, a Seattle-area startup, uses its proprietary Pattern Discovery Engine to solve the most important and most intractable problems in business and medicine. Its proprietary mathematical techniques can find complex patterns in very-high-order data that have eluded detection by much larger systems.

While the company is currently applying its computational platform to the challenging field of drug discovery, it is also making pattern discoveries for partners in several other sectors, including additional biomedical research, materials science, aerospace manufacturing, veterinary medicine, air traffic operations, and finance.

CONTACT:

 Denyse Hudson -

 360.298.0658 -

 denyse@patterncomputer.com